Jessy Delaye

667 citations
9 papers · 384 · 1 hit paper · h-index 6

Impact in

Papers in

Jessy Delaye

9 papers receiving 382 citations

Jessy Delaye's Hit Papers

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study 2018 · 229 citations
2290+2+5Years since publication50100150200

Peers

Jessy Delaye
Comparison fields: 5 of 50
  • Otorhinolaryngology 34
  • Oncology 199
  • Pulmonary and Respiratory Medicine 215
  • Cancer Research 67
  • Rheumatology 52
Replace Seiko Sawada‐Kitamura with:
Seiko Sawada‐Kitamura Japan
Aylin Örgen Çallı Türkiye
Seog-Yun Park South Korea
Rosa Rinaldi Italy
Kanae Nosaka Japan
Xiao Shi China
Dimitrios Krikelis Greece
Patricia C. Ewing‐Graham Netherlands
François‐Régis Ferrand France
Paula Fontes Asprino Brazil
Jessy Delaye relative to Seiko Sawada‐Kitamura Japan Seiko Sawada‐Kitamura's profile →
Citations per field
00.5×
Seiko Sawada‐Kitamura · 1×
Citations per year

Countries citing papers authored by Jessy Delaye

Since Specialization
Citations

This map shows the geographic impact of Jessy Delaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessy Delaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessy Delaye more than expected).

Fields of papers citing papers by Jessy Delaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessy Delaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessy Delaye. The network helps show where Jessy Delaye may publish in the future.

Co-authors

The 25 scholars most cited alongside Jessy Delaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jessy Delaye Line = papers co-authored together Jessy Delaye links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Hit paper breakdown →
2018229
2 201947
3 201927
4 201926
5 201923
6 201622
7 20194
8 20184
9 20142

About Jessy Delaye

Jessy Delaye is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 9 papers that have together received 384 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Cancer Diagnosis and Treatment (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Colorectal and Anal Carcinomas (2 papers), Neuroblastoma Research and Treatments (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Otorhinolaryngology (34 citations), Oncology (199 citations), Pulmonary and Respiratory Medicine (215 citations), Cancer Research (67 citations) and Rheumatology (52 citations). Jessy Delaye has collaborated with scholars based in France, Switzerland and Guadeloupe. Frequent co-authors include Sophie Piperno‐Neumann, Sylvie Chabaud, Emmanuelle Bompas, Florence Duffaud, Nicolas Penel, Jean‐Yves Blay, Antoîne Italiano, Olivier Collard, Camille Schiffler and Olivier Mir. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, BMJ Open, Cancer Epidemiology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact